INVO Fertility, Inc.
Key Metrics
- Previous Close
- $2.18
- 52-Week Range
- $1.59 – $91.60
- Market Cap
- $2.36M
- P/E (TTM)
- 0.00
- EPS (TTM)
- 511.80
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 0.13
- PEG Ratio
- —
- Return on Equity
- -54.13%
- Return on Assets
- -16.27%
- Gross Margin
- 35.00%
- Operating Margin
- -72.16%
- Profit Margin
- -80.74%
- Current Ratio
- 1.00
- Debt/Equity
- 0.17
- Total Debt
- $3.14M
- Free Cash Flow
- $-6.53M
- Revenue Growth
- 26.50%
- Earnings Growth
- —
- Enterprise Value
- $2.21M
Market Snapshot
About
INVO Fertility, Inc. is a medical device company focused on providing affordable fertility treatment options. The company's proprietary INVOcell device enables intravaginal culture, offering a more natural and cost-effective approach to in vitro fertilization (IVF). The INVOcell system allows fertilization and early embryo development to occur inside the woman's body rather than in a laboratory incubator. INVO Fertility aims to make fertility treatments more accessible to patients who cannot afford traditional IVF procedures, particularly in underserved markets.